Rapid emergence of methotrexate resistance in cultured mouse cells - PubMed (original) (raw)
- PMID: 6744265
Rapid emergence of methotrexate resistance in cultured mouse cells
H Rath et al. Cancer Res. 1984 Aug.
Abstract
We have examined the time required for mouse 3T6 cells to become resistant to 200 nM methotrexate by three selection protocols: (a) a single-step 0 to 200 nM dose; (b) a two-step 0 to 80 to 200 nM dose; and (c) a multistep 0 to 40 to 80 to 120 to 160 to 200 nM dose. An initial inoculum of 5 X 10(5) cells was grown to 10(6) cells at each increment of methotrexate, reduced to 5 X 10(5) cells, and again grown to 10(6) cells at the next increment. The total elapsed time required for an initial inoculum of 5 X 10(5) cells to grow to 1 X 10(6) cells resistant to 200 nM methotrexate was 45, 21, and 6.5 days, respectively, for the three drug dosage schedules. The single-step resistant variants did not contain amplified dihydrofolate reductase genes, whereas cells resistant to 200 nM methotrexate by the two stepwise selections were resistant as a result of a 6-fold amplification of the dihydrofolate reductase gene. We conclude that the resistance to 200 nM methotrexate resulting from gene amplification did not preexist in the initial population but was generated during the selection process. These results are discussed in terms of the emergence of drug resistance during the course of chemotherapy of tumors.
Similar articles
- Gene amplification and drug resistance in mammalian cells.
Schimke RT, Brown PC, Kaufman RJ. Schimke RT, et al. Natl Cancer Inst Monogr. 1982;60:79-86. Natl Cancer Inst Monogr. 1982. PMID: 7121575 - Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc.
Denis N, Kitzis A, Kruh J, Dautry F, Corcos D. Denis N, et al. Oncogene. 1991 Aug;6(8):1453-7. Oncogene. 1991. PMID: 1886715 - Acquisition and loss of amplified genes: dramatic effects of hormones, tumor promoters and cytotoxic drugs.
Varshavsky A, Barsoum J, Roninson I, Snapka R. Varshavsky A, et al. Princess Takamatsu Symp. 1983;14:235-54. Princess Takamatsu Symp. 1983. PMID: 6394591 Review. - Gene amplification and altered enzymes as mechanisms for the development of drug resistance.
Bertino JR, Carman MD, Weiner HL, Cashmore A, Moroson BA, Srimatkandada S, Schornagel JH, Medina WD, Dube SK. Bertino JR, et al. Cancer Treat Rep. 1983 Oct;67(10):901-4. Cancer Treat Rep. 1983. PMID: 6354438 Review.
Cited by
- Evaluation of stable and highly productive gene amplified CHO cell line based on the location of amplified genes.
Yoshikawa T, Nakanishi F, Itami S, Kameoka D, Omasa T, Katakura Y, Kishimoto M, Suga K. Yoshikawa T, et al. Cytotechnology. 2000 Jul;33(1-3):37-46. doi: 10.1023/A:1008111328771. Cytotechnology. 2000. PMID: 19002809 Free PMC article. - Effect of cycloheximide on development of methotrexate resistance of Chinese hamster ovary cells treated with inhibitors of DNA synthesis.
Sherwood SW, Schumacher RI, Schimke RT. Sherwood SW, et al. Mol Cell Biol. 1988 Jul;8(7):2822-7. doi: 10.1128/mcb.8.7.2822-2827.1988. Mol Cell Biol. 1988. PMID: 3405220 Free PMC article. - Ubiquitous, heritable damage in cell populations that survive treatment with methotrexate.
Chow M, Rubin H. Chow M, et al. Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8773-8. doi: 10.1073/pnas.94.16.8773. Proc Natl Acad Sci U S A. 1997. PMID: 9238053 Free PMC article. - Paradoxical signal transduction in neurobiological systems.
Colpaert FC, Frégnac Y. Colpaert FC, et al. Mol Neurobiol. 2001 Aug-Dec;24(1-3):145-68. doi: 10.1385/MN:24:1-3:145. Mol Neurobiol. 2001. PMID: 11831550 Review. - On the mechanism of gene amplification induced under stress in Escherichia coli.
Slack A, Thornton PC, Magner DB, Rosenberg SM, Hastings PJ. Slack A, et al. PLoS Genet. 2006 Apr;2(4):e48. doi: 10.1371/journal.pgen.0020048. Epub 2006 Apr 7. PLoS Genet. 2006. PMID: 16604155 Free PMC article.